ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$2.48 USD
+0.12 (5.08%)
Updated Oct 13, 2025 04:00 PM ET
After-Market: $2.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IBRX 2.48 +0.12(5.08%)
Will IBRX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for IBRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IBRX
ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates
CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success
IBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
ImmunityBio (IBRX) Moves to Buy: Rationale Behind the Upgrade
ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Other News for IBRX
IBRX forms Directional Movement Crossover Bearish on October 10
Undercovered Dozen: Petrobras, Richtech Robotics, Enbridge And More
Is IBRX likely to continue lower? Fell Below 50 Day Moving Average shows up after sliding 3.56%
Is IBRX gaining bearish strength? 20 Day Moving Average Resistance shows up after climbing 1.2%
50 Day Moving Average Support appears for IBRX after 1.19% move